Rx-to-OTCスイッチ（スイッチOTC医薬品）の世界市場レポート 2024年

Rx-to-OTCスイッチ（スイッチOTC医薬品）市場規模は、今後数年間で力強い成長が見込まれます。2028年にはCAGR8.6％で595億8,000万米ドルに成長します。予測期間中に予想される成長は、OTC医薬品に対する需要の高まり、保険・償還政策の上昇、セルフケアやセルフメディケーションに対する消費者の関心の高まり、高齢化人口の増加、OTC医薬品に対する認識と教育の向上など、いくつかの要因に起因すると考えられます。予測期間中に予想される主な動向としては、セルフケアに対する消費者の需要の増加、デジタルヘルス技術の統合、ストアブランドやプライベートブランドの成長、革新的なドラッグデリバリーシステムの開発、予防ケア製品の重視の高まりなどが挙げられます。

市販（OTC）製品に対する消費者の需要の増加は、今後のRx-to-OTCスイッチ（スイッチOTC医薬品）市場の成長を促進すると予測されます。一般用医薬品（OTC）とは、ヘルスケアの専門家から処方箋をもらわずに購入できる医薬品のことです。OTC製品の需要が急増している背景には、入手のしやすさ、時間の節約、認知度の向上と教育、デジタルヘルスの台頭、eコマース・プラットフォームの拡大など、さまざまな要因があります。OTC製品は簡単に手に入るため、処方箋を必要とせず、一般的な病気を自分で管理し、治療について十分な情報を得た上で決定することができます。この動向は、ヘルスケアにおける自律性と情報に基づく意思決定を促します。例えば2024年1月、米国の業界団体である消費者ヘルスケア製品協会（CHPA）は、OTC医薬品の小売売上高が2022年の421億米ドルから2023年には434億米ドルに増加すると報告しています。したがって、OTC製品に対する消費者の需要の高まりが、Rx-to-OTCスイッチ市場の成長を後押ししています。

Rx-to-OTCスイッチ（スイッチOTC医薬品）市場で事業展開する企業は、アレルギーによる目のかゆみなどの一般的な問題に対処するため、市販の目薬などの革新的なソリューションの開発に注力しています。市販の目薬は、処方箋なしで購入できる液体製剤で、目の表面に直接塗布します。これらの製品は、自然な涙液膜を模倣して潤滑性を与え、ドライアイの症状を緩和します。例えば、2022年3月、アイルランドに本社を置く製薬会社Allergan plcは、市販の目のアレルギーのかゆみ止めであるラスタカフトを発売しました。ラスタカフトは0.25％のアルカフタジンを含有し、眼科用抗ヒスタミン薬で、ヒスタミンH1受容体を効果的に遮断し、眼内のヒスタミンの放出を抑制することで、アレルギーによる目のかゆみを迅速かつ長時間緩和します。この特許取得済み処方は、数分以内に素早く緩和し、最大16時間持続するため、花粉、草、ブタクサ、動物の毛、ペットのフケなどのアレルゲンによって引き起こされる目のかゆみに悩む方に便利なソリューションです。ラスタキャフトは、季節性アレルギーと通年性アレルギーの両方に適しており、2歳以上の大人と子供に安全です。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界の市場規模と成長

• 世界のRx-to-OTCスイッチ（スイッチOTC医薬品）市場：促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界のRx-to-OTCスイッチ（スイッチOTC医薬品）市場の実績：規模と成長, 2018-2023
• 世界のRx-to-OTCスイッチ（スイッチOTC医薬品）市場の予測：規模と成長, 2023-2028, 2033F

第6章 市場セグメンテーション

• 世界のRx-to-OTCスイッチ（スイッチOTC医薬品）市場：製品別、実績と予測, 2018-2023, 2023-2028F, 2033F
• アレルギーと呼吸器
• 真菌感染症およびその他の感染症
• 経口避妊薬
• 胃腸薬
• その他の製品
• 世界のRx-to-OTCスイッチ（スイッチOTC医薬品）市場：流通チャネル別、実績と予測, 2018-2023, 2023-2028F, 2033F
• 小売薬局
• 病院薬局
• ドラッグストア
• オンライン薬局
• 世界のRx-to-OTCスイッチ（スイッチOTC医薬品）市場：エンドユーザー別、実績と予測, 2018-2023, 2023-2028F, 2033F
• 病院併設のラボおよび診療所
• 診断ラボ
• 学術研究機関

第7章 地域別・国別分析

• 世界のRx-to-OTCスイッチ（スイッチOTC医薬品）市場：地域別、実績と予測, 2018-2023, 2023-2028F, 2033F
• 世界のRx-to-OTCスイッチ（スイッチOTC医薬品）市場：国別、実績と予測, 2018-2023, 2023-2028F, 2033F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• Rx-to-OTCスイッチ（スイッチOTC医薬品）市場：競合情勢
• Rx-to-OTCスイッチ（スイッチOTC医薬品）市場：企業プロファイル
  • Pfizer Inc.
  • Johnson & Johnson
  • Procter & Gamble Company
  • Merck & Co. Inc
  • AbbVie Inc.

第31章 その他の大手企業と革新的企業

• Bayer AG
• Sanofi S.A.
• Bristol Myers Squibb
• AstraZeneca plc
• Abbott Laboratories
• Novartis AG
• Takeda Pharmaceutical Company Limited
• GlaxoSmithKline Plc
• Eli Lilly & Company Ltd.
• Teva Pharmaceutical Industries Ltd.
• Sandoz International GmbH
• Alcon Inc.
• Boehringer Ingelheim GmbH
• Sun Pharmaceutical Industries Ltd
• Dr Reddy's Laboratories Ltd

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと潜在的な分析

第36章 付録

Prescription to over-the-counter (Rx-to-OTC) switches denote the process of approving prescription medications for sale over-the-counter (OTC), enabling consumers to purchase them without a prescription. This transition aims to enhance drug affordability and accessibility by eliminating the need for doctor visits and prescription drug coverage.

The primary products of prescription to over-the-counter (Rx-to-OTC) switches include allergy and respiratory medications, fungal infections and other infections treatments, oral contraceptives, gastrointestinal drugs, among others. The allergy and respiratory medication category target conditions such as asthma, allergic rhinitis, and bronchitis by addressing inflammation and hypersensitivity reactions in the airways. These products are distributed through various channels including retail pharmacies, hospital pharmacies, drug stores, and online pharmacies, catering to different end-users such as hospital-based laboratories and clinics, diagnostic laboratories, and academic research institutes.

The prescription to over-the-counter (Rx-to-OTC) switches market research report is one of a series of new reports from The Business Research Company that provides prescription to over-the-counter (Rx-to-OTC) switches market statistics, including prescription to over-the-counter (Rx-to-OTC) switches industry global market size, regional shares, competitors with a prescription to over-the-counter (Rx-to-OTC) switches market share, detailed prescription to over-the-counter (Rx-to-OTC) switches market segments, market trends and opportunities, and any further data you may need to thrive in the prescription to over-the-counter (Rx-to-OTC) switches industry. This prescription to over-the-counter (Rx-to-OTC) switches market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The prescription to over-the-counter (Rx-to-OTC) switches market size has grown strongly in recent years. It will grow from $39.41 billion in 2023 to $42.76 billion in 2024 at a compound annual growth rate (CAGR) of 8.5%. The historical growth can be attributed to several factors, including the growth in consumer preference for self-care, significant investments in the healthcare sector and innovations, support from government agencies, increased awareness and knowledge about OTC products, and changes in health priorities influencing decision-making.

The prescription to over-the-counter (Rx-to-OTC) switches market size is expected to see strong growth in the next few years. It will grow to $59.58 billion in 2028 at a compound annual growth rate (CAGR) of 8.6%. The anticipated growth in the forecast period can be attributed to several factors, including the growing demand for OTC drugs, rising insurance and reimbursement policies, increasing consumer interest in self-care and self-medication, a growing aging population, and increased awareness and education about OTC medications. Major trends expected in the forecast period encompass increasing consumer demand for self-care, integration of digital health technologies, growth of store brands and private labels, development of innovative drug delivery systems, and a growing emphasis on preventive care products.

The increasing demand among consumers for over-the-counter (OTC) products is anticipated to drive the growth of the prescription to over-the-counter (Rx-to-OTC) switches market in the future. Over-the-counter (OTC) products are medications that can be purchased without a prescription from a healthcare professional. The surge in demand for OTC products can be attributed to various factors, including their accessibility, time-saving benefits, increased awareness and education, the rise of digital health, and the expansion of e-commerce platforms. OTC products provide easy accessibility, empowering individuals to manage common ailments independently and make informed decisions about their treatment without requiring a prescription. This trend encourages autonomy and informed decision-making in healthcare. For example, in January 2024, the Consumer Healthcare Products Association (CHPA), a US-based trade association, reported a rise in retail sales of OTC medicines from $42.1 billion in 2022 to $43.4 billion in 2023. Hence, the escalating consumer demand for OTC products is propelling the growth of the Rx-to-OTC switches market.

Enterprises operating in the prescription to over-the-counter (Rx-to-OTC) switches market are concentrating on developing innovative solutions, such as over-the-counter eye drops, to address common issues such as itchy eyes caused by allergies. Over-the-counter eye drops are liquid formulations that can be purchased without a prescription and applied directly to the surface of the eye. These products mimic the natural tear film and provide lubrication, offering relief from symptoms of dry eyes. For instance, in March 2022, Allergan plc, an Ireland-based pharmaceutical company, introduced LASTACAFT, an over-the-counter eye allergy itch relief product. LASTACAFT contains 0.25% alcaftadine, an ophthalmic antihistamine that effectively blocks histamine H1 receptors and inhibits the release of histamine in the eye, providing rapid and long-lasting relief for itchy eyes due to allergies. This patented formula delivers quick relief within minutes and lasts for up to 16 hours, making it a convenient solution for individuals affected by eye itching triggered by allergens such as pollen, grass, ragweed, animal hair, and pet dander. LASTACAFT is suitable for both seasonal and year-round allergies and is safe for adults and children aged 2 and above.

In December 2023, Petros Pharmaceuticals, Inc., a US-based pharmaceutical company, partnered with Idea Evolver to address the technological aspects necessary for the successful transition of STENDRA from prescription to OTC status. The collaboration aims to integrate human factors, usability engineering, and artificial intelligence components into the development process, enhancing the self-selection process for consumers. Idea Evolver, a US-based provider of technology platforms for digital Rx-to-OTC switches, brings expertise in implementing innovative technological solutions for seamless transitions in medication accessibility.

Major companies operating in the prescription to over-the-counter (Rx-to-OTC) switches market are Pfizer Inc., Johnson & Johnson, Procter & Gamble Company, Merck & Co. Inc, AbbVie Inc., Bayer AG, Sanofi S.A., Bristol Myers Squibb, AstraZeneca plc, Abbott Laboratories, Novartis AG, Takeda Pharmaceutical Company Limited, GlaxoSmithKline Plc, Eli Lilly & Company Ltd., Teva Pharmaceutical Industries Ltd., Sandoz International GmbH, Alcon Inc., Boehringer Ingelheim GmbH, Sun Pharmaceutical Industries Ltd, Dr Reddy's Laboratories Ltd, Cipla Limited, Lupin Limited, MundiPharma AG, Perrigo Company plc, Zydus Cadila

North America was the largest region in the prescription to over-the-counter (Rx-to-OTC) switches market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the prescription to over-the-counter (Rx-to-OTC) switches market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the prescription to over-the-counter (Rx-to-OTC) switches market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The prescription to over-the-counter (Rx-to-OTC) switches market includes revenues earned by entities by providing services such as public health benefits, clinical trial management, marketing and branding strategies, distribution and logistics management, pharmacovigilance and post-market surveillance. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Prescription To Over-The-Counter (Rx-to-OTC) Switches Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on prescription to over-the-counter (Rx-to-OTC) switches market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for prescription to over-the-counter (Rx-to-OTC) switches? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The prescription to over-the-counter (Rx-to-OTC) switches market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Allergy And Respiratory; Fungal Infections And Other Infections; Oral Contraceptive; Gastrointestinal Drugs; Other Products
• 2) By Distribution Channel: Retail Pharmacies; Hospital Pharmacies; Drug Stores; Online Pharmacies
• 3) By End-User: Hospital-Based Laboratories And Clinics; Diagnostic Laboratories; Academic Research Institutes
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson; Procter & Gamble Company; Merck & Co. Inc; AbbVie Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Prescription To Over-The-Counter (Rx-to-OTC) Switches Market Characteristics

3. Prescription To Over-The-Counter (Rx-to-OTC) Switches Market Trends And Strategies

4. Prescription To Over-The-Counter (Rx-to-OTC) Switches Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Prescription To Over-The-Counter (Rx-to-OTC) Switches Market Size and Growth

• 5.1. Global Prescription To Over-The-Counter (Rx-to-OTC) Switches Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Prescription To Over-The-Counter (Rx-to-OTC) Switches Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Prescription To Over-The-Counter (Rx-to-OTC) Switches Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Prescription To Over-The-Counter (Rx-to-OTC) Switches Market Segmentation

• 6.1. Global Prescription To Over-The-Counter (Rx-to-OTC) Switches Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Allergy And Respiratory
• Fungal Infections And Other Infections
• Oral Contraceptive
• Gastrointestinal Drugs
• Other Products
• 6.2. Global Prescription To Over-The-Counter (Rx-to-OTC) Switches Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Retail Pharmacies
• Hospital Pharmacies
• Drug Stores
• Online Pharmacies
• 6.3. Global Prescription To Over-The-Counter (Rx-to-OTC) Switches Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospital-Based Laboratories And Clinics
• Diagnostic Laboratories
• Academic Research Institutes

7. Prescription To Over-The-Counter (Rx-to-OTC) Switches Market Regional And Country Analysis

• 7.1. Global Prescription To Over-The-Counter (Rx-to-OTC) Switches Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Prescription To Over-The-Counter (Rx-to-OTC) Switches Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Prescription To Over-The-Counter (Rx-to-OTC) Switches Market

• 8.1. Asia-Pacific Prescription To Over-The-Counter (Rx-to-OTC) Switches Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Prescription To Over-The-Counter (Rx-to-OTC) Switches Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Prescription To Over-The-Counter (Rx-to-OTC) Switches Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Prescription To Over-The-Counter (Rx-to-OTC) Switches Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Prescription To Over-The-Counter (Rx-to-OTC) Switches Market

• 9.1. China Prescription To Over-The-Counter (Rx-to-OTC) Switches Market Overview
• 9.2. China Prescription To Over-The-Counter (Rx-to-OTC) Switches Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Prescription To Over-The-Counter (Rx-to-OTC) Switches Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Prescription To Over-The-Counter (Rx-to-OTC) Switches Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Prescription To Over-The-Counter (Rx-to-OTC) Switches Market

• 10.1. India Prescription To Over-The-Counter (Rx-to-OTC) Switches Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Prescription To Over-The-Counter (Rx-to-OTC) Switches Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Prescription To Over-The-Counter (Rx-to-OTC) Switches Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Prescription To Over-The-Counter (Rx-to-OTC) Switches Market

• 11.1. Japan Prescription To Over-The-Counter (Rx-to-OTC) Switches Market Overview
• 11.2. Japan Prescription To Over-The-Counter (Rx-to-OTC) Switches Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Prescription To Over-The-Counter (Rx-to-OTC) Switches Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Prescription To Over-The-Counter (Rx-to-OTC) Switches Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Prescription To Over-The-Counter (Rx-to-OTC) Switches Market

• 12.1. Australia Prescription To Over-The-Counter (Rx-to-OTC) Switches Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Prescription To Over-The-Counter (Rx-to-OTC) Switches Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Prescription To Over-The-Counter (Rx-to-OTC) Switches Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Prescription To Over-The-Counter (Rx-to-OTC) Switches Market

• 13.1. Indonesia Prescription To Over-The-Counter (Rx-to-OTC) Switches Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Prescription To Over-The-Counter (Rx-to-OTC) Switches Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Prescription To Over-The-Counter (Rx-to-OTC) Switches Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Prescription To Over-The-Counter (Rx-to-OTC) Switches Market

• 14.1. South Korea Prescription To Over-The-Counter (Rx-to-OTC) Switches Market Overview
• 14.2. South Korea Prescription To Over-The-Counter (Rx-to-OTC) Switches Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Prescription To Over-The-Counter (Rx-to-OTC) Switches Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Prescription To Over-The-Counter (Rx-to-OTC) Switches Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Prescription To Over-The-Counter (Rx-to-OTC) Switches Market

• 15.1. Western Europe Prescription To Over-The-Counter (Rx-to-OTC) Switches Market Overview
• 15.2. Western Europe Prescription To Over-The-Counter (Rx-to-OTC) Switches Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Prescription To Over-The-Counter (Rx-to-OTC) Switches Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Prescription To Over-The-Counter (Rx-to-OTC) Switches Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Prescription To Over-The-Counter (Rx-to-OTC) Switches Market

• 16.1. UK Prescription To Over-The-Counter (Rx-to-OTC) Switches Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Prescription To Over-The-Counter (Rx-to-OTC) Switches Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Prescription To Over-The-Counter (Rx-to-OTC) Switches Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Prescription To Over-The-Counter (Rx-to-OTC) Switches Market

• 17.1. Germany Prescription To Over-The-Counter (Rx-to-OTC) Switches Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Prescription To Over-The-Counter (Rx-to-OTC) Switches Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Prescription To Over-The-Counter (Rx-to-OTC) Switches Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Prescription To Over-The-Counter (Rx-to-OTC) Switches Market

• 18.1. France Prescription To Over-The-Counter (Rx-to-OTC) Switches Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Prescription To Over-The-Counter (Rx-to-OTC) Switches Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Prescription To Over-The-Counter (Rx-to-OTC) Switches Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Prescription To Over-The-Counter (Rx-to-OTC) Switches Market

• 19.1. Italy Prescription To Over-The-Counter (Rx-to-OTC) Switches Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Prescription To Over-The-Counter (Rx-to-OTC) Switches Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Prescription To Over-The-Counter (Rx-to-OTC) Switches Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Prescription To Over-The-Counter (Rx-to-OTC) Switches Market

• 20.1. Spain Prescription To Over-The-Counter (Rx-to-OTC) Switches Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Prescription To Over-The-Counter (Rx-to-OTC) Switches Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Prescription To Over-The-Counter (Rx-to-OTC) Switches Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Prescription To Over-The-Counter (Rx-to-OTC) Switches Market

• 21.1. Eastern Europe Prescription To Over-The-Counter (Rx-to-OTC) Switches Market Overview
• 21.2. Eastern Europe Prescription To Over-The-Counter (Rx-to-OTC) Switches Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Prescription To Over-The-Counter (Rx-to-OTC) Switches Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Prescription To Over-The-Counter (Rx-to-OTC) Switches Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Prescription To Over-The-Counter (Rx-to-OTC) Switches Market

• 22.1. Russia Prescription To Over-The-Counter (Rx-to-OTC) Switches Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Prescription To Over-The-Counter (Rx-to-OTC) Switches Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Prescription To Over-The-Counter (Rx-to-OTC) Switches Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Prescription To Over-The-Counter (Rx-to-OTC) Switches Market

• 23.1. North America Prescription To Over-The-Counter (Rx-to-OTC) Switches Market Overview
• 23.2. North America Prescription To Over-The-Counter (Rx-to-OTC) Switches Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Prescription To Over-The-Counter (Rx-to-OTC) Switches Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Prescription To Over-The-Counter (Rx-to-OTC) Switches Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Prescription To Over-The-Counter (Rx-to-OTC) Switches Market

• 24.1. USA Prescription To Over-The-Counter (Rx-to-OTC) Switches Market Overview
• 24.2. USA Prescription To Over-The-Counter (Rx-to-OTC) Switches Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Prescription To Over-The-Counter (Rx-to-OTC) Switches Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Prescription To Over-The-Counter (Rx-to-OTC) Switches Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Prescription To Over-The-Counter (Rx-to-OTC) Switches Market

• 25.1. Canada Prescription To Over-The-Counter (Rx-to-OTC) Switches Market Overview
• 25.2. Canada Prescription To Over-The-Counter (Rx-to-OTC) Switches Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Prescription To Over-The-Counter (Rx-to-OTC) Switches Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Prescription To Over-The-Counter (Rx-to-OTC) Switches Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Prescription To Over-The-Counter (Rx-to-OTC) Switches Market

• 26.1. South America Prescription To Over-The-Counter (Rx-to-OTC) Switches Market Overview
• 26.2. South America Prescription To Over-The-Counter (Rx-to-OTC) Switches Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Prescription To Over-The-Counter (Rx-to-OTC) Switches Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Prescription To Over-The-Counter (Rx-to-OTC) Switches Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Prescription To Over-The-Counter (Rx-to-OTC) Switches Market

• 27.1. Brazil Prescription To Over-The-Counter (Rx-to-OTC) Switches Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Prescription To Over-The-Counter (Rx-to-OTC) Switches Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Prescription To Over-The-Counter (Rx-to-OTC) Switches Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Prescription To Over-The-Counter (Rx-to-OTC) Switches Market

• 28.1. Middle East Prescription To Over-The-Counter (Rx-to-OTC) Switches Market Overview
• 28.2. Middle East Prescription To Over-The-Counter (Rx-to-OTC) Switches Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Prescription To Over-The-Counter (Rx-to-OTC) Switches Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Prescription To Over-The-Counter (Rx-to-OTC) Switches Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Prescription To Over-The-Counter (Rx-to-OTC) Switches Market

• 29.1. Africa Prescription To Over-The-Counter (Rx-to-OTC) Switches Market Overview
• 29.2. Africa Prescription To Over-The-Counter (Rx-to-OTC) Switches Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Prescription To Over-The-Counter (Rx-to-OTC) Switches Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Prescription To Over-The-Counter (Rx-to-OTC) Switches Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Prescription To Over-The-Counter (Rx-to-OTC) Switches Market Competitive Landscape And Company Profiles

• 30.1. Prescription To Over-The-Counter (Rx-to-OTC) Switches Market Competitive Landscape
• 30.2. Prescription To Over-The-Counter (Rx-to-OTC) Switches Market Company Profiles
  • 30.2.1. Pfizer Inc.
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Johnson & Johnson
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Procter & Gamble Company
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Merck & Co. Inc
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. AbbVie Inc.
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Prescription To Over-The-Counter (Rx-to-OTC) Switches Market Other Major And Innovative Companies

• 31.1. Bayer AG
• 31.2. Sanofi S.A.
• 31.3. Bristol Myers Squibb
• 31.4. AstraZeneca plc
• 31.5. Abbott Laboratories
• 31.6. Novartis AG
• 31.7. Takeda Pharmaceutical Company Limited
• 31.8. GlaxoSmithKline Plc
• 31.9. Eli Lilly & Company Ltd.
• 31.10. Teva Pharmaceutical Industries Ltd.
• 31.11. Sandoz International GmbH
• 31.12. Alcon Inc.
• 31.13. Boehringer Ingelheim GmbH
• 31.14. Sun Pharmaceutical Industries Ltd
• 31.15. Dr Reddy's Laboratories Ltd

32. Global Prescription To Over-The-Counter (Rx-to-OTC) Switches Market Competitive Benchmarking

33. Global Prescription To Over-The-Counter (Rx-to-OTC) Switches Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Prescription To Over-The-Counter (Rx-to-OTC) Switches Market

35. Prescription To Over-The-Counter (Rx-to-OTC) Switches Market Future Outlook and Potential Analysis

• 35.1 Prescription To Over-The-Counter (Rx-to-OTC) Switches Market In 2028 - Countries Offering Most New Opportunities
• 35.2 Prescription To Over-The-Counter (Rx-to-OTC) Switches Market In 2028 - Segments Offering Most New Opportunities
• 35.3 Prescription To Over-The-Counter (Rx-to-OTC) Switches Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer